DiabetesInControl – Tapentadol-ER for the Treatment of Diabetes Peripheral Neuropathy (DPN)

Tapentadol-ER is a schedule II opioid analgesic that is commonly used for the treatment of moderate to severe chronic pain. It is unique in its dual acting mechanism in which it works as both a weak mu-opioid receptor agonist and a norepinephrine-reuptake inhibitor.

Read more

Posted in Drugs